{"result": "(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison Principios de Medicina Interna is a medical textbook that provides comprehensive information on internal medicine, including adrenal disorders.)\n##\n(\"entity\"<|>ENDOCRINE SOCIETY<|>ORGANIZATION<|>The Endocrine Society is a professional organization that provides clinical practice guidelines for the diagnosis and treatment of endocrine disorders, including primary adrenal insufficiency.)\n##\n(\"entity\"<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>Manual de Endocrinología y Nutrición is a resource that offers guidelines and information on endocrinology and nutrition, including adrenal insufficiency.)\n##\n(\"entity\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>ORGANIZATION<|>Williams Textbook of Endocrinology is a comprehensive textbook that covers various aspects of endocrinology, including the adrenal cortex and related disorders.)\n##\n(\"entity\"<|>FEOCROMOCITOMA<|>EVENT<|>Feocromocitoma is a rare tumor that secretes catecholamines and is associated with hypertension, often requiring surgical intervention for treatment.)\n##\n(\"entity\"<|>PARAGANGLIOMA<|>EVENT<|>Paraganglioma is a type of tumor that can produce catecholamines and is often located in the head and neck region, requiring specific diagnostic imaging for localization.)\n##\n(\"entity\"<|>SDHB<|>PERSON<|>SDHB is a gene associated with hereditary syndromes that can lead to the development of tumors such as pheochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>RET<|>PERSON<|>RET is a gene that, when mutated, can be associated with certain types of tumors, including pheochromocytomas.)\n##\n(\"entity\"<|>VHL<|>PERSON<|>VHL is a gene associated with von Hippel-Lindau syndrome, which can lead to various tumors, including pheochromocytomas and renal cell carcinoma.)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ENDOCRINE SOCIETY<|>Both organizations provide guidelines and information related to the diagnosis and treatment of adrenal disorders<|>7)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Both organizations focus on endocrine disorders and provide clinical guidelines<|>7)\n##\n(\"relationship\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Both textbooks cover topics related to endocrinology and adrenal disorders<|>8)\n##\n(\"relationship\"<|>FEOCROMOCITOMA<|>PARAGANGLIOMA<|>Both are types of tumors that can produce catecholamines and are related to adrenal disorders<|>6)\n##\n(\"relationship\"<|>SDHB<|>FEOCROMOCITOMA<|>Mutations in the SDHB gene are associated with the development of pheochromocytomas<|>8)\n##\n(\"relationship\"<|>RET<|>FEOCROMOCITOMA<|>Mutations in the RET gene can lead to the development of pheochromocytomas<|>8)\n##\n(\"relationship\"<|>VHL<|>FEOCROMOCITOMA<|>Mutations in the VHL gene are associated with the risk of developing pheochromocytomas<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: rarrenal aguda.\n\nDespués de las primeras 24 horas, se puede reducir la dosis de hidrocortisona, por lo gene- ral a 50 mg por vía i.m. o i.v. cada 6 horas y después, si el paciente puede tomarla por vía oral, a hidrocortisona oral, 40 mg por la mañana y 20 mg por la tarde. A continuación, se podrá reducir a una dosis sustitutiva de 20 mg al día, dividida en dos o tres fracciones al día.\n\nReferencias:\n- Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n- Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:364-89.\n- De Miguel Novoa P. Insuficiencia adrenal primaria. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).\n- Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n\n## 5.8 Casos clínicos. Caso clínico 2\n\n### 50 Teniendo en cuenta el resultado de los análisis realizados, señale la opción correcta:\n\nA. El perfil bioquímico orienta hacia un feocromocitoma suprarrenal.\nB. Los paragangliomas de cabeza y cuello frecuentemente son productores de catecolaminas, por lo que el tumor posiblemente esté localizado en la zona yugulotimpánica.\nC. El perfil bioquímico orienta hacia un paraganglioma localizado en tórax o abdomen.\nD. Ninguna de las respuestas anteriores es cierta.\n\n### 51 ¿Cuál de las siguientes exploraciones complementarias de localización indicaría en primer lugar?\n\nA. Realizaría una gammagrafía con metayodobencilguanidina (MIBG) corporal total.\nB. Realizaría una TAC cérvico-toracoabdominal.\nC. Realizaría una RMN hipofisaria.\nD. Realizaría una ecografía cervical.\n\n### 52 Tras el diagnóstico de localización, el paciente es intervenido quirúrgicamente con resultado de tumor productor de catecolaminas, infiltrativo localmente. Señale la respuesta correcta en relación con este tipo de tumores:\n\nA. El fenotipo bioquímico no es útil como guía del estudio genético.\nB. El fenotipo bioquímico con secreción predominante de adrenalina suele estar presente en pacientes con mutaciones del gen RET y del gen VHL.\nC. La determinación de cromogranina A plasmática es una prueba altamente específica para el diagnóstico de tumores productores de catecolaminas.\nD. El fenotipo bioquímico con secreción predominante de noradrelina suele estar presente en pacientes con mutaciones del gen VHL y de SDHx.\n\n### 53 En el estudio histológico del tumor, el resultado de la inmunohistoquímica muestra SDHB negativo. ¿Qué estudio realizaría en primer lugar?\n\nA. Estudio del gen RET.\nB. Estudio del gen SDHB.\nC. Estudio del gen VHL.\nD. Estudio del gen SDHC.\n\n### 54 El estudio genético fue positivo. Respecto al seguimiento de este paciente y sus familiares, señale la respuesta correcta:\n\nA. El paciente no necesita más seguimiento, ya que tras la intervención los marcadores bioquímicos se han normalizado.\nB. En caso de mutación en el gen SDHD, la enfermedad se manifiesta con mayor frecuencia si se hereda de la madre, por lo que en este caso no sería necesario realizar estudio a sus hijos.\nC. Los pacientes con mutaciones en el gen de SDHB pueden asociar adenomas hipofisarios, tumores GIST o carcinoma papilar de tiroides.\nD. En pacientes con mutaciones en VHL se debe descartar la presencia de carcinoma renal, carcinoma de tiroides o adenomas hipofisarios.\n\nCOMENTARIO\n\nLos feocromocitomas son neoplasias infrecuentes que probablemente suponen menos de 0,2% de los pacientes con hipertensión.\n\nLa mayoría de los feocromocitomas son esporádicos; sin embargo, aproximadamente el 40% de los pacientes tienen su enfermedad en el contexto de un síndrome familiar. En ese caso, los tumores se presentan a edades más tempranas que en los casos esporádicos.\n\nHay varios tr\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}